Amgen
AMGN
2,431 hedge funds and large institutions have $98.2B invested in Amgen in 2023 Q1 according to their latest regulatory filings, with 90 funds opening new positions, 1,047 increasing their positions, 895 reducing their positions, and 144 closing their positions.
24% more call options, than puts
Call options by funds: $1.48B | Put options by funds: $1.19B
17% more repeat investments, than reductions
Existing positions increased: 1,047 | Existing positions reduced: 895
1% more capital inflows, than outflows
Capital inflows: $4.87B | Capital outflows: $4.83B
0.03% less ownership
Funds ownership: 76.01% → 75.99% (-0.03%)
3% less funds holding
Funds holding: 2,498 → 2,431 (-67)
34% less funds holding in top 10
Funds holding in top 10: 97 → 64 (-33)
38% less first-time investments, than exits
New positions opened: 90 | Existing positions closed: 144
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$812M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$362M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$214M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$213M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$213M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$532M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$458M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$371M |
| 4 |
D.E. Shaw & Co
New York
|
-$229M |
| 5 |
Barclays
London,
United Kingdom
|
-$226M |
AMGN Hedge Fund Activity: Q1 2023 in Review
2,431 of the 6,286 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2023, worth a combined $98.2B — down 7.8% from $107B a quarter earlier.
Sellers outnumbered buyers: 144 funds closed out of AMGN and 90 opened new positions — a net loss of 54 holders — while 895 trimmed existing stakes and 1,047 added.
The largest buyer was UBS AM, opening a new position worth an estimated $812M. The largest seller was JP Morgan Chase, cutting an estimated $532M.
- 2,431 institutional investors held Amgen (AMGN) as of Q1 2023, down from 2,498 in Q4 2022.
- Funds reported $98.2B of Amgen stock for Q1 2023, down 7.8% quarter-over-quarter.
- 90 funds opened new Amgen positions in Q1 2023 and 144 closed out, a net change of -54 holders.
- The largest Amgen buyer in Q1 2023 was UBS AM, an estimated $812M added.
- The largest Amgen seller in Q1 2023 was JP Morgan Chase, an estimated $532M sold.
Based on aggregated 13F filings for Q1 2023.